EXHIBIT 32.0
Published on May 15, 2008
Exhibit
32.0
CERTIFICATION
PURSUANT TO
EXCHANGE
ACT RULE 13(a)-14(b) AND 18 U.S.C. SECTION 1350
In
connection with the report of Rexahn Pharmaceuticals, Inc. (the “Company”) on
Form 10-Q for the period ended March 31, 2008, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), and pursuant to Exchange
Act Rule 13(a)-14(b) and 18 U.S.C. Section 1350, each of the undersigned
officers of the Company does hereby certify that, to the best of such officer’s
knowledge:
|
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
The
undersigned have executed this Certificate as of the 15th day of
May 2008.
|
/s/
Chang H. Ahn
|
||
|
Chang
H. Ahn
|
||
|
Chief
Executive Officer
|
||
|
/s/ Ted T.H. Jeong
|
||
|
Ted
T.H. Jeong
|
||
|
Chief
Financial Officer
|